Metastatic Prostate Cancer

被引：388

作者：

Sartor, Oliver ^{[1
]}

de Bono, Johann S. ^{[2
,3
]}

机构：

[1] Tulane Med Sch, New Orleans, LA USA

[2] Inst Canc Res, London, England

[3] Royal Marsden NHS Fdn Trust, London, England

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2018年 / 378卷 / 07期

关键词：

POST HOC ANALYSIS; ABIRATERONE ACETATE; PHASE-III; RADIOGRAPHIC PROGRESSION; 1ST-LINE CHEMOTHERAPY; INCREASED SURVIVAL; PROGNOSTIC MODEL; PLUS PREDNISONE; CLINICAL-TRIAL; CASTRATION;

D O I：

10.1056/NEJMra1701695

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Care for men with prostate cancer is a major global health care challenge, compounded by an aging population and increasing frequency of diagnosis. The priorities today are similar to those in the recent past: minimizing overtreatment of indolent disease and improving outcomes for patients with aggressive disease. Herein we focus on recent accomplishments and future challenges in the management of metastatic disease, which continues to be associated with a high rate of death despite multiple new-drug approvals in recent years. Metastatic prostate cancer can be broadly divided into two groups: disease that has not been treated with androgen deprivation and disease that is resistant to such therapy. Treating metastatic prostate cancer is becomingly increasingly complex. We review studies that are changing the standard of care, and we offer a conceptual perspective for addressing ongoing challenges and opportunities. Copyright © 2018 Massachusetts Medical Society.

引用

页码：645 / 657

页数：13

共 76 条

[41] Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis [J].

Mannweiler, Sebastian ;

Amersdorfer, Peter ;

Trajanoski, Slave ;

Terrett, Jonathan A. ;

King, David ;

Mehes, Gabor .

PATHOLOGY & ONCOLOGY RESEARCH, 2009, 15 (02) :167-172

[42] DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer [J].

Mateo, J. ;

Carreira, S. ;

Sandhu, S. ;

Miranda, S. ;

Mossop, H. ;

Perez-Lopez, R. ;

Rodrigues, D. Nava ;

Robinson, D. ;

Omlin, A. ;

Tunariu, N. ;

Boysen, G. ;

Porta, N. ;

Flohr, P. ;

Gillman, A. ;

Figueiredo, I. ;

Paulding, C. ;

Seed, G. ;

Jain, S. ;

Ralph, C. ;

Protheroe, A. ;

Hussain, S. ;

Jones, R. ;

Elliott, T. ;

McGovern, U. ;

Bianchini, D. ;

Goodall, J. ;

Zafeiriou, Z. ;

Williamson, C. T. ;

Ferraldeschi, R. ;

Riisnaes, R. ;

Ebbs, B. ;

Fowler, G. ;

Roda, D. ;

Yuan, W. ;

Wu, Y. -M. ;

Cao, X. ;

Brough, R. ;

Pemberton, H. ;

A'Hern, R. ;

Swain, A. ;

Kunju, L. P. ;

Eeles, R. ;

Attard, G. ;

Lord, C. J. ;

Ashworth, A. ;

Rubin, M. A. ;

Knudsen, K. E. ;

Feng, F. Y. ;

Chinnaiyan, A. M. ;

Hall, E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (18) :1697-1708

[43] STRUCTURE OF PORCINE LH- AND FSH-RELEASING HORMONE .1. PROPOSED AMINO ACID SEQUENCE [J].

MATSUO, H ;

BABA, Y ;

NAIR, RMG ;

ARIMURA, A ;

SCHALLY, AV .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1971, 43 (06) :1334-+

[44] Radiographic Progression-Free Survival As a Response Biomarker in Metastatic Castration-Resistant Prostate Cancer: COU-AA-302 Results [J].

Morris, Michael J. ;

Molina, Arturo ;

Small, Eric J. ;

de Bono, Johann S. ;

Logothetis, Christopher J. ;

Fizazi, Karim ;

de Souza, Paul ;

Kantoff, Philip W. ;

Higano, Celestia S. ;

Li, Jinhui ;

Thian Kheoh ;

Larson, Steven M. ;

Matheny, Shannon L. ;

Naini, Vahid ;

Burzykowski, Tomasz ;

Griffin, Thomas W. ;

Scher, Howard I. ;

Ryan, Charles J. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (12) :1356-+

[45] Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death [J].

Na, Rong ;

Zheng, S. Lilly ;

Han, Misop ;

Yu, Hongjie ;

Jiang, Deke ;

Shah, Sameep ;

Ewing, Charles M. ;

Zhang, Liti ;

Novakovic, Kristian ;

Petkewicz, Jacqueline ;

Gulukota, Kamalakar ;

Helseth, Donald L., Jr. ;

Quinn, Margo ;

Humphries, Elizabeth ;

Wiley, Kathleen E. ;

Isaacs, Sarah D. ;

Wu, Yishuo ;

Liu, Xu ;

Zhang, Ning ;

Wang, Chi-Hsiung ;

Khandekar, Janardan ;

Hulick, Peter J. ;

Shevrin, Daniel H. ;

Cooney, Kathleen A. ;

Shen, Zhoujun ;

Partin, Alan W. ;

Carter, H. Ballentine ;

Carducci, Michael A. ;

Eisenberger, Mario A. ;

Denmeade, Sam R. ;

McGuire, Michael ;

Walsh, Patrick C. ;

Helfand, Brian T. ;

Brendler, Charles B. ;

Ding, Qiang ;

Xu, Jianfeng ;

Isaacs, William B. .

EUROPEAN UROLOGY, 2017, 71 (05) :740-747

[46] Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide [J].

Noonan, K. L. ;

North, S. ;

Bitting, R. L. ;

Armstrong, A. J. ;

Ellard, S. L. ;

Chi, K. N. .

ANNALS OF ONCOLOGY, 2013, 24 (07) :1802-1807

[47] Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA [J].

Oudard, Stephane ;

Fizazi, Karim ;

Sengelov, Lisa ;

Daugaard, Gedske ;

Saad, Fred ;

Hansen, Steinbjorn ;

Hjalm-Eriksson, Marie ;

Jassem, Jacek ;

Thiery-Vuillemin, Antoine ;

Caffo, Orazio ;

Castellano, Daniel ;

Mainwaring, Paul N. ;

Bernard, John ;

Shen, Liji ;

Chadjaa, Mustapha ;

Sartor, Oliver .

JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (28) :3189-+

[48] Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer [J].

Parker, C. ;

Nilsson, S. ;

Heinrich, D. ;

Helle, S. I. ;

O'Sullivan, J. M. ;

Fossa, S. D. ;

Chodacki, A. ;

Wiechno, P. ;

Logue, J. ;

Seke, M. ;

Widmark, A. ;

Johannessen, D. C. ;

Hoskin, P. ;

Bottomley, D. ;

James, N. D. ;

Solberg, A. ;

Syndikus, I. ;

Kliment, J. ;

Wedel, S. ;

Boehmer, S. ;

Dall'Oglio, M. ;

Franzen, L. ;

Coleman, R. ;

Vogelzang, N. J. ;

O'Bryan-Tear, C. G. ;

Staudacher, K. ;

Garcia-Vargas, J. ;

Shan, M. ;

Bruland, O. S. ;

Sartor, O. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (03) :213-223

[49] Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer [J].

Petrylak, DP ;

Tangen, CM ;

Hussain, MHA ;

Lara, PN,J ;

Jones, JA ;

Taplin, ME ;

Burch, PA ;

Berry, D ;

Moinpour, C ;

Kohli, M ;

Benson, MC ;

Small, EJ ;

Raghavan, D ;

Crawford, ED .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (15) :1513-1520

[50] The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancer [J].

Pomerantz, Mark M. ;

Spisak, Sandor ;

Jia, Li ;

Cronin, Angel M. ;

Csabai, Istvan ;

Ledet, Elisa ;

Sartor, A. Oliver ;

Rainville, Irene ;

O'Connor, Edward P. ;

Herbert, Zachary T. ;

Szallasi, Zoltan ;

Oh, William K. ;

Kantoff, Philip W. ;

Garber, Judy E. ;

Schrag, Deborah ;

Kibel, Adam S. ;

Freedman, Matthew L. .

CANCER, 2017, 123 (18) :3532-3539

← 1 2 3 4 5 6 7 8 →